1
|
Maresca C, Dello Stritto A, D'Angelo C, Petti E, Rizzo A, Vertecchi E, Berardinelli F, Bonanni L, Sgura A, Antoccia A, Graziani G, Biroccio A, Salvati E. PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment. Commun Biol 2023; 6:234. [PMID: 36864251 PMCID: PMC9981704 DOI: 10.1038/s42003-023-04596-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Accepted: 02/15/2023] [Indexed: 03/04/2023] Open
Abstract
Telomeres are nucleoprotein structures at eukaryotic chromosome termini. Their stability is preserved by a six-protein complex named shelterin. Among these, TRF1 binds telomere duplex and assists DNA replication with mechanisms only partly clarified. Here we found that poly (ADP-ribose) polymerase 1 (PARP1) interacts and covalently PARylates TRF1 in S-phase modifying its DNA affinity. Therefore, genetic and pharmacological inhibition of PARP1 impairs the dynamic association of TRF1 and the bromodeoxyuridine incorporation at replicating telomeres. Inhibition of PARP1 also affects the recruitment of WRN and BLM helicases in TRF1 containing complexes during S-phase, triggering replication-dependent DNA-damage and telomere fragility. This work unveils an unprecedented role for PARP1 as a "surveillant" of telomere replication, which orchestrates protein dynamics at proceeding replication fork.
Collapse
Affiliation(s)
- C Maresca
- Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - A Dello Stritto
- Department of Biology and Biotechnology "Charles Darwin", Sapienza University of Rome, Rome, Italy
- Institute of Molecular Genetics "Luigi Cavalli-Sforza", National Research Council, Via Abbiategrasso 207, Pavia, Italy
| | - C D'Angelo
- Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - E Petti
- Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - A Rizzo
- Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - E Vertecchi
- Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy
| | | | - L Bonanni
- Department of Biology, Roma Tre University, Rome, Italy
| | - A Sgura
- Department of Biology, Roma Tre University, Rome, Italy
| | - A Antoccia
- Department of Biology, Roma Tre University, Rome, Italy
| | - G Graziani
- Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
| | - A Biroccio
- Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
| | - E Salvati
- Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
| |
Collapse
|